| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/23/1999 | CA2323729A1 Adp-glucose transporter of the amyloplast |
| 09/23/1999 | CA2323725A1 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof |
| 09/23/1999 | CA2323724A1 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | CA2323637A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
| 09/23/1999 | CA2323634A1 Lactobacilli harboring aggregation and mucin binding genes as vaccine delivery vehicles |
| 09/23/1999 | CA2323604A1 Interferon alpha plasmids and delivery systems, and methods of making and using the same |
| 09/23/1999 | CA2323494A1 Gene encoding labyrinthin, a marker for cancer |
| 09/23/1999 | CA2323238A1 Methods and compositions for diagnosis of rheumatoid arthritis |
| 09/23/1999 | CA2323095A1 Metal-containing ribonucleotide polypeptides |
| 09/23/1999 | CA2323093A1 Compounds and methods for therapy and diagnosis of lung cancer |
| 09/23/1999 | CA2323083A1 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | CA2322795A1 Metal-containing ribonucleotide polypeptides |
| 09/23/1999 | CA2322764A1 Therapeutic chemokine receptor antagonists |
| 09/23/1999 | CA2322659A1 Compositions and methods for gene-based vaccines to provoke t cell responses |
| 09/23/1999 | CA2322016A1 Genes encoding mlo proteins and conferring fungal resistance upon plants |
| 09/23/1999 | CA2321091A1 An equine neospora isolate and its uses |
| 09/23/1999 | CA2319037A1 Identification of factors which mediate the interaction of heterotrimeric g proteins and monomeric g proteins |
| 09/23/1999 | CA2263784A1 Dual-tagged proteins and their uses |
| 09/23/1999 | CA2249662A1 Novel compounds |
| 09/22/1999 | EP0943690A1 Method for refolding human activin a |
| 09/22/1999 | EP0943686A2 Protein participating in activation of nitrile hydratase,gene,plasmid and a process for producing an amide |
| 09/22/1999 | EP0943685A2 G-protein coupled receptor from human brain |
| 09/22/1999 | EP0943684A2 Frizzled-like polypeptides and polynucleotides |
| 09/22/1999 | EP0943683A1 Human vanilloid receptor homologue Vanilrep1 |
| 09/22/1999 | EP0943682A1 Tumor suppressor gene del-27 and the protein coded thereby, methods of production and use thereof |
| 09/22/1999 | EP0943681A1 Live attenuated salmonella vaccine |
| 09/22/1999 | EP0943625A1 Antibodies, production method of the antibodies, hybridomas which produce the antibodies, production method of the hybridomas and antigen proteins recognized by the antibodies |
| 09/22/1999 | EP0943624A1 Peptidic inhibitors of down-regulation of growth hormone receptor |
| 09/22/1999 | EP0943622A1 Peptide ligands for affinity purification of fibrinogen |
| 09/22/1999 | EP0943323A1 Cosmetic or dermatological composition containing at least a natural or recombinant arachnida silk protein or an analogue |
| 09/22/1999 | EP0943245A1 Vegetable protein composition containing an isoflavone- depleted vegetable protein material with an isoflavone- containing material |
| 09/22/1999 | EP0943097A1 METHOD TO DETECT IgE |
| 09/22/1999 | EP0943096A1 A PROTEIN PREPARATION THAT MEDIATES Ca2+ -DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF |
| 09/22/1999 | EP0943009A2 Species-specific, genus-specific and universal dna probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 09/22/1999 | EP0943008A1 Metal mediated serine protease inhibitors |
| 09/22/1999 | EP0943004A2 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth |
| 09/22/1999 | EP0943003A1 Insulin-like growth factor i (igf-i) expression system and methods of use |
| 09/22/1999 | EP0942998A1 Notch |
| 09/22/1999 | EP0942997A1 Chimeric ltb vaccines |
| 09/22/1999 | EP0942995A1 Novel calpaines, production and use thereof |
| 09/22/1999 | EP0942991A2 Identification of inhibitors that prevent access of telomerase to chromosomal terminus |
| 09/22/1999 | EP0942988A1 Hiv envelope polypeptides and vaccine |
| 09/22/1999 | EP0942987A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 09/22/1999 | EP0942986A1 Systems for determining substances active against hpv-associated diseases |
| 09/22/1999 | EP0942985A1 Broad-spectrum delta-endotoxins |
| 09/22/1999 | EP0942984A2 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE) |
| 09/22/1999 | EP0942983A2 $i(STREPTOCOCCUS PNEUMONIAE) ANTIGENS AND VACCINES |
| 09/22/1999 | EP0942982A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/22/1999 | EP0942981A1 Fibroblast growth factor-13 |
| 09/22/1999 | EP0942980A1 Tumor-associated kazal inhibitor with pec-60 homology |
| 09/22/1999 | EP0942979A2 Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders |
| 09/22/1999 | EP0942978A2 Methods for producing the anaphase promoting complex |
| 09/22/1999 | EP0942977A2 Nucleic acid encoding schwannomin-binding-proteins and products related thereto |
| 09/22/1999 | EP0942976A1 Human sqm1 protein homolog comprising a cell adhesion protein |
| 09/22/1999 | EP0942975A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses |
| 09/22/1999 | EP0942974A2 Secreted proteins and polynucleotides encoding them |
| 09/22/1999 | EP0942973A1 Mutants of the lag-3 proteins, products for the expression of these mutants and use |
| 09/22/1999 | EP0942972A2 E25a PROTEIN, METHODS FOR PRODUCTION AND USE THEREOF |
| 09/22/1999 | EP0942971A2 Method for altering the nutritional content of plant seed |
| 09/22/1999 | EP0942968A2 TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL V H? AND V$g(k) REGIONS AND ANTIBODIES PRODUCED THEREFROM |
| 09/22/1999 | EP0942967A1 Transgenic animal expressing a syndecan in the regions of hypothalamus |
| 09/22/1999 | EP0942964A2 Thermostable polymerases having altered fidelity |
| 09/22/1999 | EP0942959A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 09/22/1999 | EP0942935A1 A process for purifying apolipoproteins and a composition for use in the process |
| 09/22/1999 | EP0942934A2 Receptor tyrosine kinase genes |
| 09/22/1999 | EP0942933A1 Human kdel receptor |
| 09/22/1999 | EP0942932A1 Multimeric erythropoietin with increased biological activity |
| 09/22/1999 | EP0942931A2 Modulation of interactions between myosin and integrins |
| 09/22/1999 | EP0942930A2 Purification of neurotrophins |
| 09/22/1999 | EP0942929A1 Dna encoding lepidopteran-active delta-endotoxins and its use |
| 09/22/1999 | EP0942928A1 Subunit respiratory syncytial virus vaccine preparation |
| 09/22/1999 | EP0942927A1 Procedure for the purification and refolding of hpv proteins |
| 09/22/1999 | EP0942926A2 DISRUPTION OF THE MAMMALIAN Rad51 PROTEIN AND DISRUPTION OF PROTEINS THAT ASSOCIATE WITH MAMMALIAN Rad51 FOR HINDERING CELL PROLIFERATION |
| 09/22/1999 | EP0942758A2 Compounds with improved inductive effect on cartilage and bones |
| 09/22/1999 | EP0942756A2 Optical diagnostic agents for diagnosis of neurodegenerative diseases by means of near infra-red radiation (nir radiation) |
| 09/22/1999 | EP0942754A2 Conjugates useful in the treatment of prostate cancer |
| 09/22/1999 | EP0942748A1 Env-glycoprotein vaccine for protection of htlv-i and -ii infection |
| 09/22/1999 | EP0942740A2 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
| 09/22/1999 | EP0804223B1 Hgh containing pharmaceutical compositions |
| 09/22/1999 | EP0771324B1 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 09/22/1999 | EP0756449A4 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides |
| 09/22/1999 | EP0620741B1 Cytotoxic drug therapy |
| 09/22/1999 | EP0540525B1 Method of preparation of vaccines, and the use of the vaccines thus prepared |
| 09/22/1999 | EP0449948B1 Grafting genetically modified cells to treat diseases of the central nervous system |
| 09/22/1999 | CN1229439A Fusion polypeptides comprising an IgE-binding domain and a HSA component, and their diagnostic and therapeutic uses |
| 09/22/1999 | CN1229437A Polypeptides useful as immunotherapeutic agent and method of polypeptides preparation |
| 09/22/1999 | CN1229414A Multivalent compounds for cross-linking receptors and uses thereof |
| 09/22/1999 | CN1229413A Insecticidal protein toxins from xenorhabdus |
| 09/22/1999 | CN1229358A Method for generating bi-RNA-virus from synthetic RNA transcripts |
| 09/22/1999 | CN1229138A Gene for transcription factor capable of altering characters of plant and use thereof |
| 09/22/1999 | CN1228994A Pharmaceutical composition of hedgehog proteins and use thereof |
| 09/22/1999 | CN1228962A Composition and methods using nitroxides to avoid oxygen toxicity |
| 09/22/1999 | CN1228927A Vegetable protein composition containing isoflavone depleted vegetable protein material with isoflavone containing material |
| 09/21/1999 | US5955652 Plant genes for sensitivity to ethylene and pathogens |
| 09/21/1999 | US5955649 Gene expression regulatory DNA, expression cassette, expression vector and transgenic plant |
| 09/21/1999 | US5955647 Method for using tobacco mosaic virus to overproduce peptides and proteins |
| 09/21/1999 | US5955645 Thrombin receptor deficient transgenic mice |
| 09/21/1999 | US5955596 NucA protein of Haemophilus influenzae and the gene encoding that protein |
| 09/21/1999 | US5955595 Cell death regulators |
| 09/21/1999 | US5955594 Nucleic acids encoding proteins for early liver development |